UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005181 |
|---|---|
| Receipt number | R000006061 |
| Scientific Title | Phase I/II study of Irinotecan and Erlotinib in patients for EGFR mutation negative previously treated non-small-cell lung cancer. |
| Date of disclosure of the study information | 2011/03/03 |
| Last modified on | 2015/09/03 09:55:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/03/03 14:15:35 | ||
| 2 | Update | 2011/09/04 18:42:46 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2013/03/03 16:55:58 | Last follow-up date |
|
| 4 | Update | 2015/03/03 16:44:51 | Email |
|
| 5 | Update | 2015/09/03 09:55:25 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
